References
- Prinzmetal M, Bloomberg W. The use of Benzedrine for the treatment of narcolepsy. J Am Med Assoc 1935; 105: 2051–2054
- Ray O. Drugs Society and Human Behavior. C.V. Mosby Co., St. Louis, MO 1978; 277–288
- 1990 Annual Emergency Room Data. Drug Abuse Warning Network, Statistical Series 1991; 10: 34, -A:No. 10-A, US Department of Health and Human Services, Rockville, MD
- Amphetamine/Methamphetamine II. TDx Assay Manual. Abbott Laboratories, Abbott Park, IL 1993; 1–11
- D'Nicuola J, Jones R, Levine B, Smith M L. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenypropanolamine and ephedrine in urine. J Anal Toxicol 1992; 16: 211–213
- Cody J T, Schwarzhoff R. Fluoresence polarization immunoassay of amphetamine, methamphetamine, and illicit amphetamine analogues. J Anal Toxicol 1993; 17: 23–33
- Przekop M A, Manno J E, Kunsman G W, Cockerham K, Manno R. BR. Evaluation of the Abbott ADx amphetamine/methamphetamine II abused drug assay: Comparison to TDx, EMIT, and gas chromatography/mass spectrometry methods. J Anal Toxicol 1991; 15: 323–326
- Poklis A, Saady J J, Fitzgerald R L, et al. Evaluation of the new monoclonal EMI T d.a.u.TM amphetamine/methamphetamine immunoassay. Bull Soc Sci Med Grand Duche Luxemb 1990; 127(Suppl)74–87
- Fitzgerald R L, Ramos JR JM, Bogema S C, Poklis A. Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)- methamphetamine following use of nasal inhalers. J Anal Toxicol 1988; 12: 225–259
- Poklis A, Jortani S A, Brown C S, Crooks C R. Response of the EMIT II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers. J Anal Toxicol 1993; 17: 284–286
- Thurman E M, Pedersen M J, Stout R L, Martin T. Distinguishing sympathomimetic in urine by gas chromatography/mass spectrometry. J Anal Toxicol 1992; 16: 19–27
- Lemberger L, Rubin A. Physiologic Disposition of Drugs of Abuse. Spectrun Publications, New York 1976; 53–57
- Depart of Health and Human Services. Mandatory Guidelines for Federal Workplace Drug Testing Program; Final Guidelines: Notice. Federal Register. April 11, 1988
- Autry J H. Notice to all DHHS/NIDA Certified Laboratories 1990; 19, Letter Dec